Theacrine (TeaCrine)

Theacrine (1,3,7,9-tetramethyluric acid) is a purine alkaloid found in kucha tea (Camellia assamica var. kucha) and is a structural analog of caffeine, with a similar proposed mechanism (adenosine-receptor antagonism plus dopaminergic modulation) but a longer duration of action (human half-life ~20+ h vs caffeine's ~5 h; a distinctly slower onset is often claimed but not well established in human PK). Human evidence is thin and heavily conflicted: the small RCTs (n=15-60) are almost all funded by the sole manufacturer (Compound Solutions) and report mostly subjective energy/focus/mood improvements, while objective performance endpoints are largely null; the one independent crossover found only a modest attention benefit at 400 mg. No meta-analyses or independent efficacy replication. One notable finding: a single manufacturer-funded 8-week trial reported no habituation, though this was based on subjective energy/focus stability and safety markers rather than an objective tolerance challenge. Low evidence. Additive stimulant/hemodynamic effects likely when combined with caffeine.

Limited clinical evidence. Small, mostly manufacturer-funded RCTs; subjective energy benefits with largely null objective-performance results